| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 158, Issue 12 5692-5697, Copyright © 1997 by American Association of Immunologists
ARTICLES |
Y Nakamoto, LG Guidotti, V Pasquetto, RD Schreiber and FV Chisari
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.
The current study was designed to explore the relative contribution of Fas ligand (FasL), perforin, IFN-gamma, and TNF-alpha-induced death pathways in the pathogenesis of CTL-induced liver disease. Hepatitis B virus-specific CTL that are genetically unable to produce either FasL, perforin, or IFN-gamma were injected into Fas-competent and Fas- deficient hepatitis B virus transgenic mice that are either sensitive or resistant to the cytopathic effects of IFN-gamma based on the extent to which their hepatocytes retain hepatitis B surface Ag (HBsAg). The results of these experiments indicate that FasL- and perforin-dependent signals are primarily responsible for the induction of liver disease in the absence of HBsAg retention, but both signaling pathways must be activated simultaneously by the CTL in order to kill the hepatocyte in vivo. In contrast, neither FasL nor perforin are required to kill hepatocytes that retain HBsAg as long as the CTL secrete IFN-gamma on antigen recognition. Finally the results indicate that, irrespective of their HBsAg content, hepatocytes are much less sensitive to destruction by TNF-alpha than by the other death pathways. While all of these death pathways appear to be operative during a normal CTL response, the current experiments suggest that the target cell determines which pathway is dominant and selects its mode of execution.
This article has been cited by other articles:
|
|
 |
|
  H. Maier, M. Isogawa, G. J. Freeman, and F. V. Chisari PD-1:PD-L1 Interactions Contribute to the Functional Suppression of Virus-Specific CD8+ T Lymphocytes in the Liver J. Immunol., March 1, 2007; 178(5): 2714 - 2720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sitia, M. Iannacone, S. Muller, M. E. Bianchi, and L. G. Guidotti Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice J. Leukoc. Biol., January 1, 2007; 81(1): 100 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Cruise, H. M. Melief, J. Lukens, C. Soguero, and Y. S. Hahn Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell-dependent hepatic inflammation J. Leukoc. Biol., August 1, 2005; 78(2): 412 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Umemura, T. Kawabe, K. Shudo, H. Kidoya, M. Fukui, M. Asano, Y. Iwakura, G. Matsuzaki, R. Imamura, and T. Suda Involvement of IL-17 in Fas ligand-induced inflammation Int. Immunol., August 1, 2004; 16(8): 1099 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nakamoto, T. Suda, T. Momoi, and S. Kaneko Different Procarcinogenic Potentials of Lymphocyte Subsets in a Transgenic Mouse Model of Chronic Hepatitis B Cancer Res., May 1, 2004; 64(9): 3326 - 3333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Roth and H. Pircher IFN-{gamma} Promotes Fas Ligand- and Perforin-Mediated Liver Cell Destruction by Cytotoxic CD8 T Cells J. Immunol., February 1, 2004; 172(3): 1588 - 1594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kasahara, K. Ando, K. Saito, K. Sekikawa, H. Ito, T. Ishikawa, H. Ohnishi, M. Seishima, S. Kakumu, and H. Moriwaki Lack of Tumor Necrosis Factor Alpha Induces Impaired Proliferation of Hepatitis B Virus-Specific Cytotoxic T Lymphocytes J. Virol., February 15, 2003; 77(4): 2469 - 2476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nakamoto, S. Kaneko, H. Fan, T. Momoi, H. Tsutsui, K. Nakanishi, K. Kobayashi, and T. Suda Prevention of Hepatocellular Carcinoma Development Associated with Chronic Hepatitis by Anti-Fas Ligand Antibody Therapy J. Exp. Med., October 21, 2002; 196(8): 1105 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sitia, M. Isogawa, K. Kakimi, S. F. Wieland, F. V. Chisari, and L. G. Guidotti Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes PNAS, October 15, 2002; 99(21): 13717 - 13722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kakimi, T. E. Lane, S. Wieland, V. C. Asensio, I. L. Campbell, F. V. Chisari, and L. G. Guidotti Blocking Chemokine Responsive to {gamma}-2/Interferon (IFN)-{gamma} Inducible Protein and Monokine Induced by IFN-{gamma} Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus-specific Cytotoxic T Lymphocytes J. Exp. Med., December 17, 2001; 194(12): 1755 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Cao, P. Meuleman, I. Desombere, M. Sallberg, and G. Leroux-Roels In Vivo Inhibition of Anti-Hepatitis B Virus Core Antigen (HBcAg) Immunoglobulin G Production by HBcAg-Specific CD4+ Th1-Type T-Cell Clones in a hu-PBL-NOD/SCID Mouse Model J. Virol., December 1, 2001; 75(23): 11449 - 11456. [Abstract] [Full Text]
|
|
|
|
|
|
N. J. Kennedy, J. Q. Russell, N. Michail, and R. C. Budd Liver Damage by Infiltrating CD8+ T Cells Is Fas Dependent J. Immunol., December 1, 2001; 167(11): 6654 - 6662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Balkow, A. Kersten, T. T. T. Tran, T. Stehle, P. Grosse, C. Museteanu, O. Utermohlen, H. Pircher, F. von Weizsacker, R. Wallich, et al. Concerted Action of the FasL/Fas and Perforin/Granzyme A and B Pathways Is Mandatory for the Development of Early Viral Hepatitis but Not for Recovery from Viral Infection J. Virol., September 15, 2001; 75(18): 8781 - 8791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Z. Mehal, F. Azzaroli, and I. N. Crispe Antigen Presentation by Liver Cells Controls Intrahepatic T Cell Trapping, Whereas Bone Marrow-Derived Cells Preferentially Promote Intrahepatic T Cell Apoptosis J. Immunol., July 15, 2001; 167(2): 667 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Connolly, Y. H. Cho, R. Duan, J. Fikes, T. Gregorio, D. W. LaFleur, Z. Okoye, T. W. Salcedo, G. Santiago, S. Ullrich, et al. In Vivo Inhibition of Fas Ligand-Mediated Killing by TR6, a Fas Ligand Decoy Receptor J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 25 - 33. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Pan, L.-X. Duan, B. S. Sun, and M. A. Feitelson Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-{{kappa}}B J. Gen. Virol., January 1, 2001; 82(1): 171 - 182. [Abstract] [Full Text]
|
|
|
|
|
|
V. Pasquetto, S. Wieland, and F. V. Chisari Intracellular Hepatitis B Virus Nucleocapsids Survive Cytotoxic T-Lymphocyte-Induced Apoptosis J. Virol., October 15, 2000; 74(20): 9792 - 9796. [Abstract] [Full Text]
|
|
|
|
|
|
A. Ohta, M. Sekimoto, M. Sato, T. Koda, S.-i. Nishimura, Y. Iwakura, K. Sekikawa, and T. Nishimura Indispensable Role for TNF-{alpha} and IFN-{gamma} at the Effector Phase of Liver Injury Mediated by Th1 Cells Specific to Hepatitis B Virus Surface Antigen J. Immunol., July 15, 2000; 165(2): 956 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Rehermann Intrahepatic T Cells in Hepatitis B: Viral Control versus Liver Cell Injury J. Exp. Med., April 10, 2000; 191(8): 1263 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mozdzanowska, K. Maiese, and W. Gerhard Th Cell-Deficient Mice Control Influenza Virus Infection More Effectively Than Th- and B Cell-Deficient Mice: Evidence for a Th-Independent Contribution by B Cells to Virus Clearance J. Immunol., March 1, 2000; 164(5): 2635 - 2643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Loyer, P. Fontaine, S. Pion, F. Hetu, D.-C. Roy, and C. Perreault The In Vivo Fate of APCs Displaying Minor H Antigen and/or MHC Differences Is Regulated by CTLs Specific for Immunodominant Class I-Associated Epitopes J. Immunol., December 15, 1999; 163(12): 6462 - 6467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Winter, H.-M. Hu, W. J. Urba, and B. A. Fox Tumor Regression After Adoptive Transfer of Effector T Cells Is Independent of Perforin or Fas Ligand (APO-1L/CD95L) J. Immunol., October 15, 1999; 163(8): 4462 - 4472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishimura and A. Ohta A Critical Role for Antigen-Specific Th1 Cells in Acute Liver Injury in Mice J. Immunol., June 1, 1999; 162(11): 6503 - 6509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Jensen, A. A. Glass, W. R. Clark, E. J. Wing, J. F. Miller, and S. H. Gregory Fas (CD95)-Dependent Cell-Mediated Immunity to Listeria monocytogenes Infect. Immun., September 1, 1998; 66(9): 4143 - 4150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dao, W. Z. Mehal, and I. N. Crispe IL-18 Augments Perforin-Dependent Cytotoxicity of Liver NK-T Cells J. Immunol., September 1, 1998; 161(5): 2217 - 2222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Smyth, E. Krasovskis, and R. W. Johnstone Fas Ligand-Mediated Lysis of Self Bystander Targets by Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes J. Virol., July 1, 1998; 72(7): 5948 - 5954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. White and J. T. Harty Perforin-Deficient CD8+ T Cells Provide Immunity to Listeria monocytogenes by a Mechanism That Is Independent of CD95 and IFN-{gamma} but Requires TNF-{alpha} J. Immunol., January 15, 1998; 160(2): 898 - 905. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
